Back to results
US 2022/0023392 A1Published application
Stabilized pharmaceutical formulations of insulin aspart
AssigneeSanofi
InventorsOliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
Life of this patent
Estimating the term…
Abstract
Stabilized pharmaceutical formulations of insulin aspart are disclosed.
Claims29
A pharmaceutical formulation comprising
- (a) insulin aspart;
- (b) Zn(II);
- and
- (c) optionally protamine,
- wherein the pharmaceutical formulation contains less than 0.17 mg/mL sodium chloride.
2 more elements
15-16. (canceled)
Dependencies are inferred from the claim text.